Equinor
EQNR NYSE Integrated Oil & Gas Financials FY2016βFY2025
Equinor's revenue rose 2.6% to $106.5 billion in fiscal 2025. Its operating margin was 23.8%, down from 29.8% a year earlier. Free cash flow was $6.0 billion, down 18.0%. It paid out $6.2 billion in dividends and buybacks, 103% of free cash flow. The diluted share count fell 8.0%.
Last close Β· Oct 23, 2026
$48.82
5.2%About these figures. Equinor is a foreign company: it files an annual report on Form 20-F, prepared under international accounting standards (IFRS), instead of a 10-K, and no quarterly reports, so this page has fiscal years only. Its shares trade in the US as American depositary shares (ADSs), and one ADS can stand for several ordinary shares, so per-share figures are per ordinary share and the page has no market value, P/E or valuation model.
What Equinor does
No business description yet.
- Legal name
- EQUINOR ASA
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001140625-26-000013
0001140625
Revenue and margins
Equinor had $106.5B of revenue in fiscal 2025, up 2.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $6.0B in fiscal 2025, 5.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Equinor returned $6.2B to shareholders in fiscal 2025, 103% of free cash flow. The diluted share count fell 8.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Equinor can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $35.2B | $39.3B | $37.3B | $21.2B | $19.3B |
| Debt incl. finance leases | $32.9B | $31.0B | $30.6B | $28.8B | $30.1B |
| Net debt / EBITDA | β0.1x | β0.1x | β0.2x | 0.2x | 0.3x |
| Debt / equity | 0.8x | 0.6x | 0.6x | 0.7x | 0.8x |
| Interest coverage | 34.0x | 85.9x | 41.7x | 39.3x | 27.7x |
| Current ratio | 1.6x | 1.8x | 1.7x | β | β |
| Quick ratio | 1.5x | 1.7x | 1.6x | β | β |
| Total assets | $147.1B | $158.0B | $143.6B | $131.1B | $131.7B |
| Total liabilities | $108.1B | $104.0B | $95.1B | $88.8B | $91.2B |
| Shareholders' equity | $39.0B | $54.0B | $48.5B | $42.3B | $40.4B |
| Net debt (β = net cash) | β$2.3B | β$8.3B | β$6.7B | $7.5B | $10.8B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | β / 9 | β / 9 |
| Accruals ratio | β11.5% | β7.8% | β11.4% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Equinor EQNR | $127.0B | 2.6% | 23.8% | 5.6% | 25.1% | β | β | |
| Chevron CVX | $460.6B | β6.8% | β | 8.8% | 6.7% | 22.4x | 5 | Compare β |
| BP BP | β | β1.1% | 6.6% | 5.9% | 6.5% | β | β | Compare β |
| TotalEnergies TTE | β | β6.2% | β | β | 10.1% | β | β | Compare β |
| Shell SHEL | $643.5B | β6.1% | β | β | 9.6% | β | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $45.9B | $61.2B | $79.6B | $64.4B | $45.8B | $90.9B | $150.8B | $107.2B | $103.8B | $106.5B |
| Gross profit | $24.4B | $33.0B | $41.1B | $34.8B | $24.8B | $55.8B | $97.0B | $59.0B | $53.7B | $51.3B |
| Research and development | $298M | $307M | $315M | $300M | $254M | $291M | $308M | $311M | $348M | $352M |
| Operating income | $80.0M | $13.8B | $20.1B | $9.3B | β$3.4B | $33.7B | $78.8B | $35.8B | $30.9B | $25.4B |
| Interest expense | $1.0B | $1.1B | $868M | $861M | $1.0B | $990M | $918M | $857M | $787M | $917M |
| Pretax income | β$178M | $13.4B | $18.9B | $9.3B | β$4.3B | $31.6B | $78.6B | $37.9B | $31.0B | $25.1B |
| Income tax | $2.7B | $8.8B | $11.3B | $7.4B | $1.2B | $23.0B | $49.9B | $26.0B | $22.2B | $20.0B |
| Net income | β$2.9B | $4.6B | $7.5B | $1.8B | β$5.5B | $8.6B | $28.7B | $11.9B | $8.8B | $5.0B |
| Diluted EPS | β$0.91 | $1.40 | $2.27 | $0.55 | β$1.69 | $2.63 | $9.03 | $3.93 | $3.11 | $1.94 |
| Diluted shares | 3.20B | 3.27B | 3.33B | 3.33B | 3.27B | 3.25B | 3.18B | 3.03B | 2.83B | 2.60B |
| Cash flow | ||||||||||
| Cash from operations | $8.8B | $14.8B | $19.7B | $13.7B | $10.4B | $28.8B | $35.1B | $29.3B | $19.5B | $20.0B |
| Capital expenditure | $12.2B | $10.8B | $11.4B | $10.2B | $8.5B | $8.0B | $8.8B | $10.6B | $12.2B | $14.0B |
| Free cash flow | β$3.4B | $4.0B | $8.3B | $3.5B | $1.9B | $20.8B | $26.4B | $18.7B | $7.3B | $6.0B |
| Depreciation and amortization | β | β | β | β | $9.5B | $10.4B | $8.9B | $9.4B | $9.7B | $9.8B |
| Acquisitions | $0.0M | $0.0M | $3.6B | $2.3B | $0.0M | $111M | $147M | $1.2B | $1.7B | $26.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $442M | $1.1B | $321M | $3.3B | $5.6B | $6.0B | $5.9B |
| Dividends paid | $1.9B | $190M | $275M | $273M | $141M | $230M | $210M | $286M | $152M | $269M |
| Dividends and buybacks | $1.9B | $190M | $275M | $715M | $1.2B | $551M | $3.5B | $5.9B | $6.2B | $6.2B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $13.3B | $12.8B | $14.6B | $12.6B | $18.6B | $35.2B | $39.3B | $37.3B | $21.2B | $19.3B |
| Total debt | $34.2B | $31.2B | $27.0B | $26.7B | $35.7B | $32.9B | $31.0B | $30.6B | $28.8B | $30.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $24.9B | $25.8B | $26.1B | $24.8B | $30.8B | $61.8B | $77.2B | $61.0B | β | β |
| Current liabilities | $16.7B | $19.0B | $16.6B | $19.6B | $19.5B | $39.0B | $43.5B | $35.7B | β | β |
| Inventory | $3.2B | $3.4B | $2.1B | $3.4B | $3.1B | $3.4B | $5.2B | $3.8B | $4.0B | $3.3B |
| Property and equipment, net | $59.6B | $63.6B | $65.3B | $71.8B | $68.5B | $62.1B | $56.5B | $58.8B | β | β |
| Total assets | $104.5B | $111.1B | $112.5B | $119.9B | $124.8B | $147.1B | $158.0B | $143.6B | $131.1B | $131.7B |
| Total liabilities | $69.4B | $71.2B | $69.5B | $78.7B | $90.9B | $108.1B | $104.0B | $95.1B | $88.8B | $91.2B |
| Shareholders' equity | $35.1B | $39.9B | $43.0B | $41.1B | $33.9B | $39.0B | $54.0B | $48.5B | $42.3B | $40.4B |
| Margins | ||||||||||
| Gross margin | 53.1% | 53.9% | 51.6% | 54.1% | 54.2% | 61.3% | 64.3% | 55.1% | 51.8% | 48.2% |
| Operating margin | 0.2% | 22.5% | 25.3% | 14.5% | β7.5% | 37.0% | 52.3% | 33.4% | 29.8% | 23.8% |
| EBITDA margin | β | β | β | β | 13.3% | 48.5% | 58.2% | 42.1% | 39.1% | 33.1% |
| Net margin | β6.4% | 7.5% | 9.5% | 2.9% | β12.0% | 9.4% | 19.1% | 11.1% | 8.5% | 4.7% |
| FCF margin | β7.4% | 6.6% | 10.5% | 5.5% | 4.2% | 22.9% | 17.5% | 17.4% | 7.0% | 5.6% |
| Returns | ||||||||||
| Return on capital | β | 12.1% | 17.7% | 8.4% | β5.1% | 38.4% | 95.6% | 40.9% | 33.7% | 25.1% |
| Return on capital employed | β | 15.3% | 21.4% | 9.5% | β3.3% | 31.6% | 70.8% | 32.2% | β | β |
| Return on equity | β | 12.3% | 18.2% | 4.4% | β14.7% | 23.5% | 61.8% | 23.2% | 19.4% | 12.2% |
| Return on assets | β | 4.3% | 6.7% | 1.6% | β4.5% | 6.3% | 18.8% | 7.9% | 6.4% | 3.8% |
| Growth | ||||||||||
| Revenue growth | β23.1% | 33.4% | 30.1% | β19.1% | β28.8% | 98.5% | 65.9% | β28.9% | β3.2% | 2.6% |
| Net income growth | β | β | 64.2% | β75.5% | β399.0% | β | 235.7% | β58.7% | β25.9% | β42.7% |
| EPS growth | β | β | 62.1% | β75.8% | β407.3% | β | 243.4% | β56.5% | β20.9% | β37.6% |
| FCF growth | β | β | 105.8% | β57.4% | β46.1% | 987.8% | 27.0% | β29.2% | β61.0% | β18.0% |
| Share count change | 0.5% | 2.3% | 1.8% | 0.0% | β1.7% | β0.7% | β1.9% | β4.9% | β6.6% | β8.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | 2.8x | β0.1x | β0.1x | β0.2x | 0.2x | 0.3x |
| Debt / equity | 1.0x | 0.8x | 0.6x | 0.7x | 1.1x | 0.8x | 0.6x | 0.6x | 0.7x | 0.8x |
| Interest coverage | 0.1x | 12.7x | 23.2x | 10.8x | β3.3x | 34.0x | 85.9x | 41.7x | 39.3x | 27.7x |
| Current ratio | 1.5x | 1.4x | 1.6x | 1.3x | 1.6x | 1.6x | 1.8x | 1.7x | β | β |
| Quick ratio | 1.3x | 1.2x | 1.4x | 1.1x | 1.4x | 1.5x | 1.7x | 1.6x | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | 26.6% | 17.6% | 14.3% | 15.9% | 18.5% | 8.8% | 5.8% | 9.9% | 11.7% | 13.1% |
| Payouts / FCF | β | 4.7% | 3.3% | 20.2% | 62.8% | 2.7% | 13.4% | 31.5% | 84.6% | 103.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 7.0 | 6.0 | 5.0 | 9.0 | 9.0 | 5.0 | β | β |
| Accruals ratio | β | β9.5% | β10.9% | β10.3% | β13.0% | β14.9% | β4.2% | β11.5% | β7.8% | β11.4% |
Source: SEC EDGAR XBRL filings (CIK 0001140625). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.